Cancer testes antigens in breast cancer: Biological role, regulation, and therapeutic applicability

International Reviews of Immunology

Volumn 31, Issue 5, 2012, Pages 302-320

  Pandey, Apurva ^a   Kurup, Abhishek ^b   Shrivastava, Arpan ^a   Radhi, Saba ^a   Nguyen, Diane D ^a   Arentz, Candy ^a   D'Chuna, Nicholas ^a   Hardwick, Fred ^a   D'Souza, Martin J ^c   Jenkins, Marjorie ^a,d   Grizzi, Fabio ^a,i   Kast, W Martin ^e,g   Cobos, Everardo ^a,d   Rahman, Rakhshanda ^d,f   Chiriva Internati, Maurizio ^a,d,g   Chiaramonte, Raffaella ^h   Platonova, Natalia ^h  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b University of California at Irvine   (United States)

^c MERCER UNIVERSITY   (United States)

^d Center for Women's Health and Gender Based Medicine   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^g Kiromic Inc   (United States)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Biomarker; Breast cancer; Cancer testis antigen; Cancer vaccine; Immunotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BORIS PROTEIN; CANCER TESTIS ANTIGEN; CANCER VACCINE; CT X ANTIGEN; DNA VACCINE; ETOPOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELANOMA ANTIGEN; MELANOMA ANTIGEN 2; MELANOMA ANTIGEN A1; MELANOMA ANTIGEN A2; MELANOMA ANTIGEN A4; MESSENGER RNA; NY ESO 1 ANTIGEN; PROTEINASE; RQCD1 PROTEIN; SPERM PROTEIN 17; TESTIS SPECIFIC PROTEASE 50; TRANSCRIPTION FACTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNIZATION; CARBOXY TERMINAL SEQUENCE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TRANSCRIPTION REGULATION;

ANTIGENS, NEOPLASM; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MAMMARY GLANDS, HUMAN; MOLECULAR TARGETED THERAPY; TESTIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84867788275     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2012.723511     Document Type: Article

References (0)